Skip to content

News and Publications

Clinical milestones, company announcements and published research.

Company updatesNov 14, 2026
Alan Rudolph to present on behalf of PhotonPharma at the Personalized Cancer Vaccine Summit in Boston, December 1–3, 2026
personalized-cancer-vaccines.com
Company updatesFeb 5, 2026
PhotonPharma Inc. announces recruitment for the Phase 1 clinical trial of Innocell™ autologous cellular immunotherapy for recurrent epithelial ovarian cancer
prnewswire.com
Company updatesJan 22, 2026
PhotonPharma Inc. appoints vaccine innovation leader William Warren, PhD, to its board of directors
prnewswire.com
Media coverageJan 15, 2026
In first human trial, zombie cancer cells train the body to fight tumors (Singularity Hub)
singularityhub.com
Media coverageDec 17, 2025
Can you fight cancer with cancer? A CSU scientist is trying to find out (The Colorado Sun)
coloradosun.com
Company updatesOct 1, 2025
PhotonPharma Inc. CEO to present the Innocell platform at a premier cancer immunotherapy conference
prnewswire.com
Company updatesSep 8, 2025
PhotonPharma Inc. receives U.S. patent for its cancer immunotherapy
prnewswire.com
Company updatesSep 4, 2024
PhotonPharma to present at the Rocky Mountain Life Sciences Investor and Partnering Conference
prnewswire.com
Company updatesAug 21, 2024
PhotonPharma secures $2.5 million in seed funding to advance its ovarian cancer clinical trial
prnewswire.com
Company updatesMar 5, 2024
PhotonPharma, Inc. receives FDA clearance for a first-in-human clinical study in stage III/IV ovarian cancer with Innocell™
prnewswire.com
Media coverageDec 2021
Formulating autologous therapies for cancer (BioPharm International)
photonpharmaceuticals.com
Company updatesAug 11, 2021
PhotonPharma and Terumo Blood and Cell Technologies announce a collaboration to develop Innocell™
terumo.com
Company updatesMar 2021
Savannah Snell selected as a Boehringer Ingelheim International Veterinary Scholar at Colorado State University
PhotonPharma
ResearchSep 2020
Innocell canine trial results published (Journal of Immunology Research)
hindawi.com
ResearchMay 2020
PhotonPharma published in Vox Sanguinis
onlinelibrary.wiley.com
Company updatesNov 2019
Biotech Showcase presentation
ebdgroup.knect365.com
Company updatesSep 2019
NoCo Bio Summit — Amanda Guth
colorado.edu
Company updatesSep 2018
CSU Infectious Disease Research Center newsletter
research.colostate.edu
Company updatesJul 2018
CSU Infectious Disease Research Center
research.colostate.edu
Company updatesDate not listed
Conference announcement: 2026 Rocky Mountain Life Sciences Investor and Partnering Conference
cobioscience.com
Company updatesDate not listed
Sara Sellers joins PhotonPharma from Colorado State University
PhotonPharma
Media coverageDate not listed
CSU Ventures innovator highlight — Raymond Goodrich, PhD
csuventures.org
Media coverageDate not listed
Blood-cleansing method faces its first test as cancer vaccine (Science)
science.org
Company updatesDate not listed
PhotonPharma named a finalist in the Colorado BioScience Association awards
cobioscience.com
Media coverageDate not listed
Terumo and PhotonPharma partner to develop a cancer vaccine (BioProcess International)
bioprocessintl.com
Company updatesDate not listed
PhotonPharma awarded a Colorado OEDIT Advanced Industries early-stage grant of $248,350
oedit.colorado.gov

Media contact: Corporate Communications, +1 303 521 8401, VRay@I3MedTech.com